Prelack Steven Insider Trades

Insider Trading History

Track insider trading activity for Prelack Steven. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aerpio Pharmaceuticals
Aerpio Pharmaceuticals ARPO
Director
Holding Value $53.9k 24,485 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.8k 12,334 shares
$1.69
$2.20
Aadi Bioscience
Aadi Bioscience AADI
Director
Holding Value $50.2k 24,485 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.8k 12,334 shares
$1.69
$2.05
Aadi Bioscience
Aadi Bioscience AADI
Director
Holding Value $24.9k 12,151 shares
Last Trade
Mar 31, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.7k 12,151 shares
$1.29
$2.05
Aerpio Pharmaceuticals
Aerpio Pharmaceuticals ARPO
Director
Holding Value $26.7k 12,151 shares
Last Trade
Mar 31, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.7k 12,151 shares
$1.29
$2.20
Aadi Bioscience
Aadi Bioscience AADI
Director
Holding Value $107k 52,144 shares
Last Trade
Jun 24, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63.6k 52,144 shares
$1.22
$2.05
Aerpio Pharmaceuticals
Aerpio Pharmaceuticals ARPO
Director
Holding Value $115k 52,144 shares
Last Trade
Jun 24, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63.6k 52,144 shares
$1.22
$2.20
Aadi Bioscience
Aadi Bioscience AADI
Director
Holding Value $43.9k 21,400 shares
Last Trade
Jun 18, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.5k 21,400 shares
$0.96
$2.05
Aerpio Pharmaceuticals
Aerpio Pharmaceuticals ARPO
Director
Holding Value $47.1k 21,400 shares
Last Trade
Jun 18, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.5k 21,400 shares
$0.96
$2.20
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.38M 20,000 shares
$219.20
$13.60
Aadi Bioscience
Aadi Bioscience AADI
Director
Holding Value $43.9k 21,400 shares
Last Trade
Jun 20, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$2.05
Aerpio Pharmaceuticals
Aerpio Pharmaceuticals ARPO
Director
Holding Value $47.1k 21,400 shares
Last Trade
Jun 20, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$2.20
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.4M 20,000 shares
$617.60
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.22M 20,000 shares
$160.80
$13.60
Galectin Therapeutics
Galectin Therapeutics GALT
Director
Holding Value $97.5k 41,500 shares
Last Trade
Dec 15, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.9k 41,500 shares
$0.89
$2.35
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Feb 16, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.54M 20,000 shares
$127.20
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $0 0 shares
Last Trade
Jun 29, 2015 Sale
$119k 30,000 shares
$3.98
$13.60
Galectin Therapeutics
Galectin Therapeutics GALT
Director
Holding Value $0 0 shares
Last Trade
Apr 08, 2015 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$76k 22,882 shares
$3.32
$2.35
Galectin Therapeutics
Galectin Therapeutics GALT
Director
Holding Value $252k 107,189 shares
Last Trade
Apr 08, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$309k 93,141 shares
$3.32
$2.35
Galectin Therapeutics
Galectin Therapeutics GALT
Director
Holding Value $33k 14,048 shares
Last Trade
Mar 12, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40k 11,112 shares
$3.60
$2.35
Galectin Therapeutics
Galectin Therapeutics GALT
Director
Holding Value $14.7k 6,269 shares
Last Trade
Nov 18, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58.2k 12,437 shares
$4.68
$2.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up